Naringin Alleviates Autistic‐Like Behaviors in <scp>BTBR</scp> Mice Through Cannabinoid Receptor Type 1‐Mediated Restoration of Hippocampal Neurogenesis
This research highlights the potential of naringin as a promising treatment option for autism spectrum disorder (ASD) and suggests that targeting hippocampal neurogenesis through the CB1 receptor may be an effective strategy.
Authors
- Xiaotang Fan (ORCID: https://orcid.org/0000-0001-5694-1828)
- Tianyao Liu (ORCID: https://orcid.org/0000-0002-7646-5969)
- Meiling Xia (ORCID: https://orcid.org/0000-0002-1805-3413)
- Yulong Liu (ORCID: https://orcid.org/0009-0002-9610-1975)
- Meng Gong (ORCID: https://orcid.org/0000-0002-1203-5820)
- Yi Luo (ORCID: https://orcid.org/0000-0003-0007-0394)
- Xinggao Zhang
- Hong Gong (ORCID: https://orcid.org/0000-0003-4393-1078)
- Lian Wang (ORCID: https://orcid.org/0000-0002-8793-7335)
- Jiayin Liu (ORCID: https://orcid.org/0000-0002-8884-7710)
- Jing Luo
- Mei Chen
- Jinghui Zhao (ORCID: https://orcid.org/0000-0002-4564-8543)
Institutions
- Army Medical University (CN)
- Ministry of Education (SA)
Publication Details
- Journal
- CNS Neuroscience & Therapeutics
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1111/cns.70654
- Citations
- 1
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39